Results 1 to 10 of about 9,042 (268)

Joint Damage Prediction in Non-Severe Hemophilia A with Artificial Intelligence [PDF]

open access: yesJournal of Blood Medicine
Ana Marco-Rico,1 José Manuel Calvo-Villas,2 Francisco-Jose Lopez-Jaime,3 Mariana Canaro Hirnyk,4 María del Mar Nieto-Hernández,5 Sonia Herrero Martín,6 Laura Entrena-Ureña,7 Shally Marcellini-Antonio,8 Bolivar L Diaz-Jordan,9 Sergio Jurado-Herrera,10 ...
Marco-Rico A   +15 more
doaj   +2 more sources

DRGs in Transfusion Medicine and Hemotherapy in Germany [PDF]

open access: bronze, 2012
Patients requiring transfusion medicine and hemotherapy in an inpatient setting are incorporated into the German Diagnosis Related Groups (G-DRG) system in multiple ways.
Bauer, Matthäus, Ostermann, Helmut
core   +4 more sources

Caplacizumab treatment in elderly patients with iTTP: Experience from the Spanish TTP Registry [PDF]

open access: yesHemaSphere
Immune thrombotic thrombocytopenic purpura (iTTP) typically affects middle‐aged individuals, although it sometimes appears in older patients. Caplacizumab is approved for the treatment of iTTP, but information on the safety and efficacy of this drug in ...
Inés Gómez‐Seguí   +20 more
doaj   +2 more sources

TO EVALUATE THE PERCEPTION OF NURSING PROFESSIONALS IN THE USE OF A MONITORING INSTRUMENT IN THE HEMOTHERAPY PROCESS IN AN ONCOLOGY HOSPITAL IN THE STATE OF SÃO PAULO

open access: diamondHematology, Transfusion and Cell Therapy
Introduction: A specific instrument for monitoring the transfusion process was designed with the aim of managing, monitoring and tracking all stages of the transfusion process, in the Hemotherapy Service of the Cancer Institute of the State of São Paulo (
SRS Lira   +7 more
doaj   +2 more sources

Anti-HLA antibody formation increases the chances of platelet refractoriness in platelet-transfused patients: a systematic review with meta-analysis [PDF]

open access: yesHematology, Transfusion and Cell Therapy
Platelet refractoriness caused by alloimmunization to anti-HLA antibodies remains present in daily hemotherapy: the frequent need for platelet transfusions may influence the long-term survival of treated patients. This study aimed to perform a systematic
Luana Joana Barreto Cabral   +5 more
doaj   +2 more sources

Nursing in hemotherapy services: considerations on public policies associated with blood and blood components [PDF]

open access: yesRevista Brasileira de Enfermagem, 2022
Objective: Reflect on how the evolution of legislation related to blood and blood-based products has shaped the role of nurses in hemotherapy services. Methods: A reflective study, carried out employing surveys in databases, about the evolution of the ...
Patrícia Aparecida Tavares Mendes   +3 more
doaj   +1 more source

Hemotherapy with New Blood Products [PDF]

open access: bronzeTransfusion Medicine and Hemotherapy, 2018
Korte, Wolfgang, Zeerleder, Sacha S.
openaire   +4 more sources

Viral Metagenomics for Identification of Emerging Viruses in Transfusion Medicine

open access: yesViruses, 2022
Viral metagenomics has revolutionized our understanding for identification of unknown or poorly characterized viruses. For that reason, metagenomic studies gave been largely applied for virus discovery in a wide variety of clinical samples, including ...
Svetoslav Nanev Slavov
doaj   +1 more source

Clinical management of six cases of low-risk primary tonsillar non-Hodgkin´s lymphoma [PDF]

open access: yes, 1999
CONTEXT: There have been many reports that favor aggressive systemic treatment with chemotherapy and radiotherapy, even for well-localized lymphomas, avoiding the need for tonsillectomy of the normal tonsil.
Alves, Antonio Correa   +6 more
core   +11 more sources

AUTOLOGOUS HEMATOPOIETC CELL TRANSPLANTATION (HCT) FOR HODGKIN LYMPHOMA, REAL WORLD EXPERIENCE OF A SINGLE CENTER EXPERIENCE

open access: yesHematology, Transfusion and Cell Therapy, 2023
Objective: Hodgkin's Lymphoma (HL) during the years became a high curable hematology malignant disease. Despite high curable rates, up to 30% of patient will relapse or will be refractory to first line therapy (R/R).
Carmino De Souza   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy